CLINICAL_TRIALS
trial_result
· 2014-06-23
Clinical Trial Update: A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily [Phase 3]
Summary
Phase 3 trial comparing GSK1349572 50mg once daily to raltegravir 400mg twice daily completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I | Phase 3 | Status: COMPLETED | Results posted: 2014-06-23